Literature DB >> 18787417

Comedo-ductal carcinoma in situ: A paradoxical role for programmed cell death.

Malathy P V Shekhar1, Larry Tait, Robert J Pauley, Gen Sheng Wu, Steven J Santner, Pratima Nangia-Makker, Varun Shekhar, Hind Nassar, Daniel W Visscher, Gloria H Heppner, Fred R Miller.   

Abstract

Comedo-DCIS is a histologic subtype of preinvasive breast neoplasia that is characterized by prominent apoptotic cell death and has greater malignant potential than other DCIS subtypes. We investigated the mechanisms of apoptosis in comedo-DCIS and its role in conversion of comedo-DCIS to invasive cancer. Clinical comedo-DCIS excisions and the MCF10DCIS.com human breast cancer model which produces lesions resembling comedo-DCIS were analyzed. Apoptotic luminal and myoepithelial cells were identified by TUNEL and reactivity to cleaved PARP antibody and cell death assessed by Western blotting, Mitocapture and immunohistochemical assays. MCF10DCIS.com cells undergo spontaneous apoptosis in vitro, both in monolayers and multicellular spheroids; it is associated with increased mitochondrial membrane permeability, increase in Bax/Bcl-2 ratio and occurs via caspase-9-dependent p53-independent pathway. This suggests that apoptosis is stromal-independent and that the cells are programmed to undergo apoptosis. Immunostaining with cleaved PARP antibody showed that myoepithelial apoptosis occurs before lesions progress to comedo-DCIS in both clinical comedo-DCIS and in vivo MCF10DCIS.com lesions. Intense staining for MMP-2, MMP-3, MMP-9 and MMP-11 was observed in the stroma and epithelia of solid DCIS lesions prior to conversion to comedo-DCIS in clinical and MCF10DCIS.com lesions. Gelatin zymography showed higher MMP-2 levels in lysates and conditioned media of MCF10DCIS. com cells undergoing apoptosis. These data suggest that signals arising from the outside (microenvironmental) and inside (internal genetic alterations) of the duct act in concert to trigger apoptosis of myoepithelial and luminal epithelial cells. Our findings implicate spontaneous apoptosis in both the etiology and progression of comedo-DCIS. It is possible that spontaneous apoptosis facilitates elimination of cells thus permitting expansion and malignant transformation of cancer cells that are resistant to spontaneous apoptosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787417      PMCID: PMC4657570          DOI: 10.4161/cbt.7.11.6781

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  38 in total

1.  Cellular kinetics and expression of bcl-2 and p53 in ductal carcinoma of the breast.

Authors:  T Megha; F Ferrari; F Arcuri; A V Lalinga; S Lazzi; C Cardone; G Cevenini; L Leoncini; P Tosi
Journal:  Oncol Rep       Date:  2000 May-Jun       Impact factor: 3.906

2.  MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ.

Authors:  F R Miller; S J Santner; L Tait; P J Dawson
Journal:  J Natl Cancer Inst       Date:  2000-07-19       Impact factor: 13.506

Review 3.  Noncaspase proteases in apoptosis.

Authors:  D E Johnson
Journal:  Leukemia       Date:  2000-09       Impact factor: 11.528

4.  Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.

Authors:  M J van de Vijver; J L Peterse; W J Mooi; P Wisman; J Lomans; O Dalesio; R Nusse
Journal:  N Engl J Med       Date:  1988-11-10       Impact factor: 91.245

5.  DNA ploidy in intraductal breast carcinomas.

Authors:  T A Aasmundstad; O A Haugen
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

Review 6.  The significance of focal myoepithelial cell layer disruptions in human breast tumor invasion: a paradigm shift from the "protease-centered" hypothesis.

Authors:  Yan-Gao Man; Qing-Xiang Amy Sang
Journal:  Exp Cell Res       Date:  2004-12-10       Impact factor: 3.905

7.  Multipotent human breast stem cell line MCF1OAT.

Authors:  L Tait; P Dawson; S Wolman; K Galea; F Miller
Journal:  Int J Oncol       Date:  1996-08       Impact factor: 5.650

8.  Serine proteases mediate apoptosis-like cell death and phagocytosis under caspase-inhibiting conditions.

Authors:  L Egger; J Schneider; C Rhême; M Tapernoux; J Häcki; C Borner
Journal:  Cell Death Differ       Date:  2003-10       Impact factor: 15.828

9.  Incidence of and treatment for ductal carcinoma in situ of the breast.

Authors:  V L Ernster; J Barclay; K Kerlikowske; D Grady; C Henderson
Journal:  JAMA       Date:  1996-03-27       Impact factor: 56.272

10.  Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast.

Authors:  A Gandhi; P A Holland; W F Knox; C S Potten; N J Bundred
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

View more
  24 in total

1.  Comparative analysis of loss of heterozygosity and expression profile in normal tissue, DCIS and invasive breast cancer.

Authors:  Michal Zikan; Jan Bohm; David Pavlista; David Cibula
Journal:  Clin Transl Oncol       Date:  2011-09       Impact factor: 3.405

2.  Cullin-3 protein expression levels correlate with breast cancer progression.

Authors:  Kelly K Haagenson; Larry Tait; Juan Wang; Malathy P Shekhar; Lisa Polin; Wei Chen; Gen Sheng Wu
Journal:  Cancer Biol Ther       Date:  2012-07-24       Impact factor: 4.742

3.  Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts.

Authors:  Ashwani Khurana; Deok Jung-Beom; Xiaoping He; Sung-Hoon Kim; Robert C Busby; Laura Lorenzon; Massimo Villa; Alfonso Baldi; Julian Molina; Matthew P Goetz; Viji Shridhar
Journal:  Clin Exp Metastasis       Date:  2013-02-15       Impact factor: 5.150

4.  Ocimum gratissimum retards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteases.

Authors:  Pratima Nangia-Makker; Tirza Raz; Larry Tait; Malathy P V Shekhar; Hong Li; Vitaly Balan; Hemanckur Makker; Rafael Fridman; Krishnarao Maddipati; Avraham Raz
Journal:  Cancer Biol Ther       Date:  2013-02-04       Impact factor: 4.742

5.  Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells.

Authors:  Alexandra C Silveira; Douglas R Hurst; Kedar S Vaidya; Donald E Ayer; Danny R Welch
Journal:  Cancer Lett       Date:  2008-12-13       Impact factor: 8.679

6.  Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.

Authors:  M Sharma; A H Beck; J A Webster; I Espinosa; K Montgomery; S Varma; M van de Rijn; K C Jensen; R B West
Journal:  Breast Cancer Res Treat       Date:  2009-12-01       Impact factor: 4.872

7.  N-Acetylglucosaminyltransferase III (GnT-III) but not N-Acetylgalactosaminyltransferase-6 and 8 are Differentially Expressed in Invasive and In Situ Ductal Carcinoma of the Breast.

Authors:  Antônio Felix da Silva Filho; Gabriela Souto Vieira-de-Mello; Petra Barros Dos Santos; Moacyr Jesus Barreto de Melo Rêgo; Alfredo Ribeiro-Silva; Eduardo Isidoro Carneiro Beltrão
Journal:  Pathol Oncol Res       Date:  2019-01-28       Impact factor: 3.201

8.  Genome based cell population heterogeneity promotes tumorigenicity: the evolutionary mechanism of cancer.

Authors:  Christine J Ye; Joshua B Stevens; Guo Liu; Steven W Bremer; Aruna S Jaiswal; Karen J Ye; Ming-Fong Lin; Lesley Lawrenson; Wayne D Lancaster; Markku Kurkinen; Joshua D Liao; C Gary Gairola; Malathy P V Shekhar; Satya Narayan; Fred R Miller; Henry H Q Heng
Journal:  J Cell Physiol       Date:  2009-05       Impact factor: 6.384

9.  Myoepithelial cell differentiation markers in ductal carcinoma in situ progression.

Authors:  Tanya D Russell; Sonali Jindal; Samiat Agunbiade; Dexiang Gao; Megan Troxell; Virginia F Borges; Pepper Schedin
Journal:  Am J Pathol       Date:  2015-09-04       Impact factor: 4.307

10.  Gold nanoparticle conjugated Rad6 inhibitor induces cell death in triple negative breast cancer cells by inducing mitochondrial dysfunction and PARP-1 hyperactivation: Synthesis and characterization.

Authors:  Brittany Haynes; Yanhua Zhang; Fangchao Liu; Jing Li; Sarah Petit; Hend Kothayer; Xun Bao; Andrew D Westwell; Guangzhao Mao; Malathy P V Shekhar
Journal:  Nanomedicine       Date:  2015-11-10       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.